Purdue Pharma on Wednesday filed a new bankruptcy reorganization plan to resolve mass lawsuits alleging that the OxyContin maker and its Sackler family owners contributed to the opioid crisis.

So far, Taunton has distributed $67,600 to a variety of groups and individuals. Here's who has gotten money and why.

The proposed solution? A new bill that would impose major regulations on the state’s booming new sports betting industry.

Purdue Pharma submitted a new bankruptcy plan Tuesday, which will give its creditors more than $7.4 billion in cash—including up to $7 billion in payments from the billionaire Sackler family ...

Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the company’s alleged role in the opioid crisis, months after the Supreme ...

Third-party releases may no longer provide a shield to owners and directors of a reorganized company. Still, a New York bankruptcy court ...

Purdue Pharma has filed a new reorganization plan that aims to deliver more than $7.4 billion in cash to creditors, subject to certain reserves, to compensate victims and abate the opioid crisis.

Previously at the epicenter of the U.S. opioid crisis, Purdue Pharma is looking to reenter the public lexicon as a new public benefit company. After a prior bankruptcy settlement was nixed by the ...

Members of the Sackler family who own the OxyContin maker Purdue Pharma would hand over the company and up to $7 billion in cash in the latest plan to settle thousands of lawsuits over the toll of ...

Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court last year.

Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step towards finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court ...